Tanya Vapnik
University of California, Los Angeles
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tanya Vapnik.
International Clinical Psychopharmacology | 2005
Kenneth A. Kobak; Leslie V. H. Taylor; Alexander Bystritsky; Cary J. Kohlenberg; John H. Greist; Phebe Tucker; Gemma Warner; Rise Futterer; Tanya Vapnik
Although St Johns wort (Hypericum perforatum) is one of the most widely used and studied herbal medicines for depression, less is known about its efficacy in anxiety disorders, in spite of the fact that patients with anxiety disorders are among the most likely to self-medicate using alternative treatments. Pharmacokinetic evidence for the serotonergic, domaminergic and GABAminergic activity of hypericum, and a recent successful open-label study, suggests that it may be effective for obsessive–compulsive disorder (OCD). Sixty subjects were randomized to 12 weeks of treatment with St Johns wort (LI 160) or matching placebo. Subjects with Hamilton Depression Scale scores of 16 or above were excluded. A flexible-dose schedule was utilized (600–1800 mg/day). The mean change on the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS) with St Johns wort (3.43) was not significantly different than the mean change found with placebo (3.60) (P=899). No significant differences were found on any of the Y-BOCS subscales. The percentage of patients rated as ‘much’ or ‘very much’ improved at endpoint was not significantly different between St Johns wort (17.9%) and placebo (16.7%) (P=0.905). Only one patient from each group discontinued due to adverse events [sinus infection (St Johns wort); confusion (placebo)]. The results fail to support the efficacy of St Johns wort for OCD.
Biological Psychiatry | 1995
Alexander Bystritsky; Michelle G. Craske; Emanuel Maidenberg; Tanya Vapnik; David Shapiro
Ten patients with panic disorder and 10 matched control subjects were compared as to their blood pressure and heart rate during regular daily activity. Physiological responses were monitored by ambulatory recorder, and subjective reports of mood were collected. Data were analyzed controlling for activity and stress level of the subjects. Diastolic blood pressure emerged as a possible discriminatory factor between the groups. A trend for higher heart rate occurred in the panic group. In behavioral terms, panic patients tended to avoid anxiety-provoking situations, resulting in anxiety ratings comparable to those of the control group. Thus, recorded physiological differences between the groups may reflect heightened baseline autonomic activity in panic patients.
The Journal of Clinical Psychiatry | 2002
Sanjaya Saxena; Karron M. Maidment; Tanya Vapnik; Gina Golden; Tanya Rishwain; Richard Rosen; Gerald Tarlow; Alexander Bystritsky
The Journal of Clinical Psychiatry | 2004
Alexander Bystritsky; Deborah L. Ackerman; Richard Rosen; Tanya Vapnik; Eda Gorbis; Karron M. Maidment; Sanjaya Saxena
Depression and Anxiety | 2001
Alexander Bystritsky; Robert Paul Liberman; Sun Hwang; Charles J. Wallace; Tanya Vapnik; Karron Maindment; Sanjaya Saxena
Journal of Psychiatric Research | 2011
Sanjaya Saxena; Catherine R. Ayers; Karron M. Maidment; Tanya Vapnik; Julie Loebach Wetherell; Alexander Bystritsky
Psychiatric Services | 1999
Alexander Bystritsky; Sanjaya Saxena; Karron M. Maidment; Tanya Vapnik; Gerald Tarlow; Richard Rosen
The Journal of Clinical Psychiatry | 2001
Sanjaya Saxena; Arie Winograd; Jennifer J. Dunkin; Karron M. Maidment; Richard Rosen; Tanya Vapnik; Gerald Tarlow; Alexander Bystritsky
The Journal of Clinical Psychiatry | 2005
Ann M. Bogan; Lorrin M. Koran; Helen W. Chuong; Tanya Vapnik; Alexander Bystritsky
Psychopharmacology Bulletin | 2008
Alexander Bystritsky; Lauren Kerwin; Jamie D. Feusner; Tanya Vapnik